-
Mashup Score: 16HLA-DRB1*01:03 and Severe Ulcerative Colitis - 8 month(s) ago
This Danish nationwide genome-wide association study aims to identify biomarkers of severe vs less severe ulcerative colitis.
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7Lilly reports one-year histologic outcomes in Phase 3 study of mirikizumab compared to ustekinumab for Crohn's disease | Eli Lilly and Company - 8 month(s) ago
The Investor Relations website contains information about Eli Lilly and Company’s business for stockholders, potential investors, and financial analysts.
Source: investor.lilly.comCategories: General Medicine News, PayerTweet-
New data presented at #UEGWeek broaden our understanding of Crohn’s disease. See what this means for patients and providers: https://t.co/3ysQxMhOzG https://t.co/aZeJgOJYlc
-
-
Mashup Score: 6
To our knowledge, this is the largest trial of a tricyclic antidepressant in IBS ever conducted. Titrated low-dose amitriptyline was superior to placebo as a second-line treatment for IBS in primary care across multiple outcomes, and was safe and well tolerated. General practitioners should offer low-dose amitriptyline to patients with IBS whose symptoms do not improve with first-line therapies, with appropriate support to guide patient-led dose titration, such as the self-titration document developed for this trial.
Source: www.thelancet.comCategories: Gastroenterology, Latest HeadlinesTweet-
New online @TheLancet - Amitriptyline at Low-Dose and Titrated for #IBS as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial Catch the #UEGWeek presentation this pm by @alex_ford12399 https://t.co/R0GOVRv3s7
-
-
Mashup Score: 1Diagnosis and Management of Nonalcoholic Fatty Liver Disease - 2 year(s) ago
This JAMA Clinical Guidelines Synopsis summarizes the American Association of Clinical Endocrinology’s 2022 clinical practice guideline for diagnosis and management of nonalcoholic fatty liver disease.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
This JAMA Clinical Guidelines Synopsis summarizes the American Association of Clinical Endocrinology’s 2022 clinical practice guideline for diagnosis and management of nonalcoholic fatty liver disease. cc: #UEGWeek2023 #UEGWeek https://t.co/GHeNalA47p
-
-
Mashup Score: 0
All doses of ABX464 significantly improved moderate-to-severe, active ulcerative colitis compared with placebo, as measured by changes in MMS from baseline to week 8. A phase 3 clinical programme is ongoing.
Source: www.thelancet.comCategories: Gastroenterology, Latest HeadlinesTweet-
#UEGWeek Severine Vermeire presented data from the 96-week open label extension study of obefazimod, showing promising durability from the 48-week data published in our journal last year👇https://t.co/xqfNHWoeSK
-
-
Mashup Score: 0
Focus on fibrosis, inspired by the Review on p633.
Source: www.nature.comCategories: Gastroenterology, Latest HeadlinesTweet-
Need some reading in your #UEGweek lunchbreak? Then check out our Focus issue on liver fibrosis, selected content is FREE to access for a limited time https://t.co/zB6A4dQEOx https://t.co/TgPJdeuhZP
-
-
Mashup Score: 1About The Lancet Gastroenterology & Hepatology - 2 year(s) ago
About
Source: www.thelancet.comCategories: Gastroenterology, Latest HeadlinesTweet-
Attending #UEGWeek? Hugh Thomas, Deputy Editor, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: https://t.co/qmHGdpodEl https://t.co/6MNOVoYr4n
-
-
Mashup Score: 0UEG Interview: Jeanin van Hooft - 2 year(s) ago
When I was a trainee, I thought: am I going to be a surgeon or am I going to go into internal medicine? At that stage, we had a doctor…
Source: European Medical JournalCategories: Gastroenterology, Latest HeadlinesTweet-
In our recent interview, Jeanin van Hooft discusses how UEG @my_ueg brings together experts in the area and the future of gastrointestinal endoscopy research. Read now 👉 https://t.co/pJh4q9QL4k #UEGWeek #medicalinnovation
-
-
Mashup Score: 2UEG Week 2022 - 3 year(s) ago
Results of the REACT-2 trial, presented by Vipul Jairath (London, ON, Canada) suggest that treating to a target of ulcer healing was no more effective than standard symptom-based management for patients with Crohn’s disease. In this cluster-randomised trial, eligible practices were randomly assigned to an enhanced care algorithm (incorporating early adalimumab and antimetabolite combination…
Categories: Gastroenterology, Latest HeadlinesTweet-
News - coverage of some of the highlights among the research presented at #UEGWeek - https://t.co/QbMLDZO50e #gitwitter https://t.co/Cr8qj3Udj0
-
-
Mashup Score: 0
VIENNA — In a Healio video exclusive, Waqqas Afif, MD, reports results from the phase 3 UNIFI study, in which Stelara safely demonstrated sustained symptomatic and corticosteroid-free remission in adults with ulcerative colitis. According to Afif, 65% of patients who responded to the induction dose of Stelara (ustekinumab, Janssen) were in remission after 44 weeks of maintenance therapy. At
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI from #UEGWeek 2022: #Stelara safe, effective for the long-term treatment of moderate to severe #UC @my_ueg #GITwitter #MedTwitter https://t.co/2PvgZV56jh
-
A study of patients with ulcerative colitis identified the HLA-DRB1*01:03 allele as significantly associated with severe disease course, including increased risk for major surgery, hospitalization, and need for high-dose steroids. #UEGWeek https://t.co/URgpflOZx7 https://t.co/7SZgdUQyAk